Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Page 4 of 7
Jun 10, 2026Automated algorithms for sepsis detection are increasingly deployed in clinical settings to support rapid intervention, but their reliability can be compromised by the quirks, biases, and time-dependent inconsistencies inherent in medical data. Evaluating why sepsis algorithms sometimes fail and what can be improved is crucial as AI continues to transform patient care and diagnostics.
Jun 8, 2026Fine-tuned AI models are now being trained on real-world clinical operations data, enabling the translation of complex trial histories into actionable insights. This paradigm shift is poised to modernize the way clinical trials are designed and executed, potentially streamlining protocol creation, improving feasibility assessments, and optimizing resource utilization.
Jun 4, 2026Alnylam Pharmaceuticals is moving decisively into AI-driven drug development through a partnership with Inceptive Nucleics. This collaboration promises to accelerate RNAi therapy creation by applying cutting-edge generative machine learning models.
Jun 3, 2026This analysis delves into the themes of the pope's encyclical on AI, examining how its principles relate to healthcare delivery in Catholic institutions and beyond, with a focus on ethical considerations and AI integration.
May 29, 2026The application of artificial intelligence in healthcare continues to evolve, particularly in radiology, where AI technologies are revolutionizing image analysis. Beyond diagnostics, the introduction of a patient comprehension layer powered by AI has the potential to facilitate clearer communication of complex medical information.
May 27, 2026Amid a growing interest and rapid adoption of artificial intelligence in health benefits administration, employers are confronted with pivotal concerns that could affect the sustainable integration of AI technologies. This post explores the dynamics of this transformation, the results of a recent WTW survey, and the challenges impacting both employers and employees.
May 22, 2026The integration of artificial intelligence in healthcare communication strategies is enabling more effective alignment between patients and providers. By utilizing omnichannel engagement, AI can deliver timely and contextual information, improving patient understanding and decision-making.
May 20, 2026The use of artificial intelligence in healthcare is expanding rapidly, with recent examples highlighting its role in uncovering treatments for ultra-rare diseases and enhancing healthcare delivery through innovative AI tools. These advancements reflect AI’s growing capability to address complex medical challenges and improve patient care.
May 16, 2026The acquisition reflects a growing trend in healthcare automation where companies seek to build proprietary and specialized AI technology to streamline operations and improve service delivery. This move by IKS Health is aimed at consolidating their technological backbone to better support the healthcare sector’s evolving demands.
May 6, 2026As artificial intelligence continues to advance within healthcare, physical therapists explore how to incorporate AI effectively and ethically into musculoskeletal (MSK) care. Establishing trust in these technologies and implementing clear operational rules are critical for successful integration.
Apr 29, 2026Artificial Intelligence in healthcare has generated widespread interest, but early exuberance has gradually given way to deeper analysis. Industry experts are now focused on assessing AI's true capabilities, validation studies, and thoughtful integration into drug development and clinical care.
Apr 6, 2026As AI technologies rapidly advance, UnitedHealth Group’s major investment signals a strategic commitment to integrating AI across its healthcare operations. This initiative could redefine how healthcare providers interact with patients, optimize treatment protocols, and streamline administrative processes.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.